[1]
Anilkumar J Shinde, Karan B Swami, Firoj A Tamboli, and Harinath N More, “Design and development of zolmitriptan niosomal in situ nasal gel for the treatment of migrain”, Int. J. Res. Pharm. Sci., vol. 12, no. 3, pp. 1861–1869, Jul. 2021.